Chimeric Antigen Receptor News and Research

RSS
Researchers decipher how the immune system memorizes pathogens after an infection

Researchers decipher how the immune system memorizes pathogens after an infection

Challenges in High Complexity Flow Cytometry

Challenges in High Complexity Flow Cytometry

NCCN's first patient and caregiver resource focused on childhood leukemia

NCCN's first patient and caregiver resource focused on childhood leukemia

Research uncovers potential cause of neurotoxicity due to immunotherapy

Research uncovers potential cause of neurotoxicity due to immunotherapy

Drug used in rheumatoid arthritis and cancer treatment improves survival in critically ill COVID-19 patients

Drug used in rheumatoid arthritis and cancer treatment improves survival in critically ill COVID-19 patients

Researchers identify drug that improves survival in critically ill COVID-19 patients

Researchers identify drug that improves survival in critically ill COVID-19 patients

Targeting SARS-CoV-2 with off-the-shelf CAR-NK cells

Targeting SARS-CoV-2 with off-the-shelf CAR-NK cells

NCI gives 'exceptional' rating to Penn's Abramson Cancer Center

NCI gives 'exceptional' rating to Penn's Abramson Cancer Center

First CAR T-cell therapy for mantle cell lymphoma receives FDA approval

First CAR T-cell therapy for mantle cell lymphoma receives FDA approval

Combining two immunotherapies into a single treatment found to be more effective

Combining two immunotherapies into a single treatment found to be more effective

Research could lead to more efficient cellular immunotherapies for advanced cancers

Research could lead to more efficient cellular immunotherapies for advanced cancers

Promising new CAR T cell therapy results in exceptional patient recovery

Promising new CAR T cell therapy results in exceptional patient recovery

Study identifies possible factors to predict severe toxicities in CAR T patients

Study identifies possible factors to predict severe toxicities in CAR T patients

Scientists engineer natural killer cells that target tumors and their immunosuppressive allies

Scientists engineer natural killer cells that target tumors and their immunosuppressive allies

New NCCN guidelines explain how to recognize and manage immunotherapy-related side effects

New NCCN guidelines explain how to recognize and manage immunotherapy-related side effects

Researchers receive innovative grants to understand the biological underpinnings of blood cancers

Researchers receive innovative grants to understand the biological underpinnings of blood cancers

Producing CAR T cell therapy at a lower cost

Producing CAR T cell therapy at a lower cost

Repurposing immunosuppressants to manage COVID-19

Repurposing immunosuppressants to manage COVID-19

Damon Runyon Cancer Research Foundation awards $3.2 million to early-career physician-scientists

Damon Runyon Cancer Research Foundation awards $3.2 million to early-career physician-scientists

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors